Intervention 1: Intervention group: Patients are treated with Xyla-P cream. A 5% Xyla-P cream is a combination of 2.5% lidocaine and 2.5% perlocaine produced by Iranian chemistry company Iran. For eac

2 trials

Sponsors

Esfahan University of Medical Sciences

Conditions

Procedural pain.Procedural pain. Acute pain, not elsewhere classified

Phase 3

Evaluation of the effect of lidocaine-ibuprofen cream in reducing local pain

RecruitingIRCT20180129038549N10

Esfahan University of Medical SciencesProcedural pain. Acute pain, not elsewhere classified

Start: 2021-05-16Target: 100Updated: 2021-05-26

Evaluation of the effect of lidocaine-diclofenac cream in reducing local pain

Active, not recruitingIRCT20180129038549N11

Esfahan University of Medical SciencesProcedural pain.

Start: 2020-01-15Target: 100Updated: 2021-05-26